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Abstract
Cell fusion occurs when several cells combine to form a multinuclear aggregate (syncytium). In human placenta, a
syncytialized trophoblast (syncytiotrophoblast) layer forms the primary interface between maternal and fetal tissue,
facilitates nutrient and gas exchange, and produces hormones vital for pregnancy. Syncytiotrophoblast development
occurs by differentiation of underlying progenitor cells called cytotrophoblasts, which then fuse into the
syncytiotrophoblast layer. Differentiation is associated with chromatin remodeling and specific changes in gene
expression mediated, at least in part, by histone acetylation. However, the epigenetic regulation of human
cytotrophoblast differentiation and fusion is poorly understood. In this study, we found that human
syncytiotrophoblast development was associated with deacetylation of multiple core histone residues. Chromatin
immunoprecipitation sequencing revealed chromosomal regions that exhibit dynamic alterations in histone H3
acetylation during differentiation. These include regions containing genes classically associated with cytotrophoblast
differentiation (TEAD4, TP63, OVOL1, CGB), as well as near genes with novel regulatory roles in trophoblast
development and function, such as LHX4 and SYDE1. Prevention of histone deacetylation using both pharmacological
and genetic approaches inhibited trophoblast fusion, supporting a critical role of this process for trophoblast
differentiation. Finally, we identified the histone deacetylases (HDACs) HDAC1 and HDAC2 as the critical mediators
driving cytotrophoblast differentiation. Collectively, these findings provide novel insights into the epigenetic
mechanisms underlying trophoblast fusion during human placental development.
Introduction
Cell fusion into a syncytium is the process whereby
several cells coalesce to form a multinucleated entity, and
features in homeostasis of several normal tissues and
pathologies (e.g., cancer, virus infection, inflammation)1,2.
One of the best paradigms of syncytium formation occurs
in the placenta—the organ that forms the interface
between a pregnant mother and her baby. The placental
exchange surface is lined by a syncytium, called syncy-
tiotrophoblast, which produces hormones and facilitates
transfer of nutrients and gases between maternal and fetal
blood. Syncytiotrophoblast is formed by fusion of
underlying progenitor cells called cytotrophoblasts3.
Continuous fusion of cytotrophoblasts is crucial for syn-
cytiotrophoblast to expand and replenish, ensuring proper
function of the exchange surface throughout pregnancy4.
Dysregulation of syncytiotrophoblast formation leads to
poor placental function, and is associated with several
highly prevalent pregnancy complications that are detri-
mental to maternal and fetal health5–7.
Syncytiotrophoblast nuclei exhibit a wide range of dis-
tinctive chromatin condensation patterns, with some
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nuclei demonstrating an open euchromatic appearance
and others possessing a more heterochromatic state.
Previous studies have indicated that syncytiotrophoblast
nuclei are transcriptionally inert based on assessing
uptake of [3H]-uridine, which correlates with the high
number of heterochromatic nuclei8,9. Follow-up studies
show that at least some nuclei are transcriptionally
active10. These studies infer that cytotrophoblast pro-
gression into syncytiotrophoblast is associated with
altered chromatin dynamics, which may be required for
the robust changes in transcription required for syncy-
tiotrophoblast formation and function.
Histone acetylation is an epigenetic modification in
which an acetyl group is covalently added to lysine resi-
dues on histone tails protruding from nucleosomes, and is
a key determinant of chromatin accessibility11. The
dynamics of histone acetylation in regulating chromatin
structure is fundamentally important for the precise
timing and level of gene transcription. Histone acetylation
is catalyzed by enzymes with acetyltransferase activity,
and is associated with open chromatin regions and active
transcription. Deacetylation is typically associated with
chromatin condensation, and is performed by enzymes
called histone deacetylases (HDACs)12. Although HDACs
are classically associated with inactive transcription, both
acetyltransferases and HDACs bind to chromatin near
sites of actively transcribed regions, where they function
cooperatively to fine-tune histone acetylation and facil-
itate binding of machinery required for transcription13.
HDACs are arranged into four distinct classes, of which
class I, II, and IV have a zinc-dependent active site that is
inhibited by trichostatin A (TSA). Class I HDACs reside
in nuclei, and consist of HDAC1, HDAC2, HDAC3, and
HDAC8. Class II HDACs shuttle between nucleus and
cytoplasm, and include HDAC4, HDAC5, HDAC6,
HDAC7, HDAC9, and HDAC10. HDAC11 is the sole
member of class IV14. Class III HDACs are a distinct
family identified as sirtuins, which depend on nicotina-
mide adenine dinucleotide for deacetylase activity15.
Due to their critical role as regulators of chromatin
accessibility and gene transcription, histone acetylation
dynamics serve a crucial role in the control of cell pro-
liferation and differentiation16. For example, HDAC1
regulates embryonic stem cell differentiation17,18, and
controls lineage-specific transcriptional networks in
mouse embryonic and trophoblast stem cells19. Blocking
HDAC activity in mouse trophoblast stem cells promotes
labyrinth trophoblast development at the expense of giant
cell and spongiotrophoblast formation20. Class II HDACs
are important for proper trophoblast differentiation in
mouse placentas21, and mouse trophoblast stem cells
lacking Sirtuin-1 show blunted cell differentiation22. In
human trophoblasts, HDAC inhibition impairs expression
of the efflux protein P-glycoprotein, and the cortisol
metabolizing enzyme 11β-hydroxysteroid dehy-
drogenase23,24. Recent derivation of human trophoblast
stem cells was made possible, in part, by using an HDAC
inhibitor to maintain cells in a stem state, suggesting a
critical role for HDAC activity in human trophoblast
differentiation25. Indeed, differentiation of primary
human cytotrophoblasts is associated with profound
changes in histone acetylation, including gene- and
promoter-specific changes in H3K9 and H3K27 acetyla-
tion26. Collectively, these studies emphasize the critical
role of histone acetylation dynamics and HDAC activity in
the regulation of trophoblast differentiation and placental
development, which prompted us to investigate the
functional role of specific HDACs during human syncy-
tiotrophoblast formation.
In this study, we found that histone acetylation
decreases as trophoblast cells and cell lines differentiate
into syncytiotrophoblast, and that HDAC1 and HDAC2
activity is required for cytotrophoblast differentiation. We
identified several genomic regions in which acetylation
patterns are altered during cytotrophoblast differentiation
that correlate with robust changes in gene transcription
required for differentiation. Collectively, our results reveal
a critical role of HDACs for the regulation of cyto-
trophoblast differentiation, and provide new insights into
the epigenetic regulation of human syncytiotrophoblast
formation.
Results
Expression of acetylated histone proteins in human
placenta and differentiating cytotrophoblasts
To evaluate localization of acetylated histone proteins in
human placenta, we performed immunohistochemistry to
detect acetylated histone H2B K5 (AcH2BK5), acetylated
histone H3 (AcH3) K9, AcH3K27, AcH3K14, and
AcH3K18 in 6-week and 39-week human placenta. All
acetylated histone lysine residues were identified in both
cytotrophoblasts (identified using E-cadherin) and syn-
cytiotrophoblast in 6-week placentas (Fig. 1a). Acetylated
histones were also detected in the villous core. In 39-week
placentas, few cytotrophoblasts were visible, and staining
intensity of acetylated histone proteins in syncytio-
trophoblast appeared to be lower than in early gestation
placentas. Interestingly, patterns of histone acetylation
were not consistent between cells of the same lineage,
with some cells exhibiting robust expression of histone
acetylation and other cells with low-to-undetectable
expression. These findings indicate that histone acetyla-
tion patterns in the human placenta are dynamic, and may
be associated with altered function or developmental
progression within placental cells. Since images represent
a snapshot of the human placenta and we cannot confirm
the developmental stage of each cell, we sought to analyze
histone acetylation patterns in primary cytotrophoblasts,
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where cells exhibit synchrony in terms of their develop-
mental progression.
Immunofluorescence for cytokeratin-7 was used to
evaluate the purity of the isolated cytotrophoblast popu-
lations (Fig. 1b). Cytotrophoblasts were then lysed
immediately before plating (0 h), or cultured for 24, 48, or
72 h, during which time they spontaneously differentiate
into syncytiotrophoblast and produce high levels of the
syncytiotrophoblast hormone subunit chorionic gonado-
tropin beta (CGB) (Fig. 1b). Interestingly, levels of
Fig. 1 Histone acetylation patterns in human placenta and primary cytotrophoblasts. a Localization of AcH2BK5, AcH3K9, AcH3K27, AcH3K14,
and AcH3K18 in 6-week and 39-week human placenta. In all panels, cytotrophoblasts were detected by immunostaining for E-cadherin (red), and
nuclei were counterstained using DAPI (blue). Arrowheads denote the syncytiotrophoblast layer. b Primary cytotrophoblasts were isolated from term
human placenta, and cultured for 24, 48, and 72 h. At the 24-h timepoint, KRT7 (red) was detected by immunofluorescence to validate that these cells
were trophoblasts. Nuclei were counterstained using DAPI (blue). CGB production was determined in conditioned media by enzyme immunoassay.
c Levels of AcH2BK5, AcH3K9, AcH3K27, AcH3K14, AcH3K18, AcH3, and total histone H3 (loading control) were determined by western blotting (n=
4). Densitometric analysis relative to total histone H3 is shown beside the representative western blots. The dotted line represents signal intensity in
undifferentiated cells. Graphs represent means ± SEM. Data significantly different from undifferentiated cells are indicated by an asterisk (*P < 0.05;
n= 4 from different placentas). Scale bars represent 40 μm.
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AcH3K27, AcH3K14, and AcH3 significantly decreased at
72 h differentiation (Fig. 1c). Levels of AcH2BK5,
AcH3K9, and AcH3K18 appeared to be decreased, but did
not reach statistical significance (P= 0.058, P= 0.082, and
P= 0.080, respectively).
Next, we investigated patterns of histone acetylation in
recently-derived human trophoblast stem cells maintained
in the stem state, or following differentiation into syncy-
tiotrophoblast. When induced to differentiate toward the
syncytiotrophoblast lineage, human trophoblast stem cells
exhibit increased expression of ERVFRD-1 (4.7-fold,
encodes syncytin-2), CGB (579.9-fold), and HSD11B2
(22.4-fold, encodes the glucocorticoid-inactivating enzyme
corticosteroid 11-β-dehydrogenase isozyme 2), and
decreased expression of TP63 (17-fold; all P < 0.05,
Fig. 2a). CGB is also highly detectable at the protein level
(Fig. 2b). Not surprisingly, during TS cell differentiation
toward syncytiotrophoblast, removal of the HDAC inhi-
bitor valproic acid (used as a media component to main-
tain these cells in a stem state) correlated with reduced
levels of AcH2BK5, AcH3K9, AcH3K27, AcH3K14,
AcH3K18, and AcH3 as early as one day after onset of
differentiation (all P < 0.05, Fig. 2c). The reduced acetyla-
tion during syncytialization is consistent with our obser-
vations in primary cytotrophoblasts. After four days of
syncytiotrophoblast development, levels of histone
Fig. 2 Reduced histone acetylation during syncytialization of human trophoblast stem cells. a Transcript levels of ERVFRD-1, CGB, HSD11B2,
and TP63 in human trophoblast stem cells cultured in stem conditions, and following 5 days culture in conditions that promote syncytiotrophoblast
formation. b Detection of CGB in human trophoblast stem cells cultured in stem and differentiation conditions. Nuclei were counterstained using
DAPI (blue). c Levels of AcH2BK5, AcH3K9, AcH3K27, AcH3K14, AcH3K18, AcH3, and total H3 were determined by western blotting. Densitometric
analysis relative to total histone H3 on day 1 and day 4 of syncytialization is shown to the right of the western blots. The dotted line represents signal
intensity in undifferentiated cells. Graphs represent means ± SEM. Data significantly different from undifferentiated cells are indicated by an asterisk
(P < 0.05; n= 3). Scale bars represent 100 μm.
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acetylation remained lower than in the undifferentiated
state, although only AcH3K14 and AcH3K18 were statis-
tically significant.
To further examine histone acetylation patterns during
cytotrophoblast differentiation, we used BeWo tropho-
blasts—a transformed cytotrophoblast cell line that is
commonly used to study dynamics of cytotrophoblast
differentiation into syncytiotrophoblast. The advantage of
using these cells is that onset of differentiation can be
precisely timed by exposing cells to a cell-permeable
derivative of 3′, 5′-cyclic adenosine monophosphate (8-
Br-cAMP), resulting in decreased surface expression of
junctional proteins such as E-cadherin and increased
production of CGB (Fig. 3a). Differentiation of BeWo
trophoblasts was associated with increased mRNA
expression of CGB (130.5-fold, P < 0.05), HSD11B2 (78.9-
fold, P < 0.05), ERVW1 (1.6-fold, encodes syncytin-1),
ERVFRD-1 (36.7-fold, P < 0.05), the retroviral genes
ERVV1 and ERVV2 (13.4-fold and 15.1-fold, respectively,
both P < 0.05), and OVOL1 (36.8-fold, encodes a tran-
scriptional repressor essential for cytotrophoblast
differentiation, P < 0.05; Fig. 3b). Differentiation was also
associated with decreased expression of genes encoding
transcription factors associated with cytotrophoblast
progenitor traits (TP63: 2.6-fold; TEAD4: 3.8-fold; Fig. 3b,
P < 0.05). At the protein level, differentiation was asso-
ciated with a 22.5-fold upregulation of CGB, and reduced
levels of AcH2BK5, AcH3K9, and AcH3 (62%, 46%, and
31% decreased at 48 h differentiation compared with
undifferentiated cells, respectively; Fig. 3c, all P < 0.05).
Levels of AcH3K27, AcH3K14, and AcH3K18 appeared to
be reduced in differentiated cells, but did not reach sta-
tistical significance (P= 0.22, P= 0.058, and P= 0.13,
respectively). Thus, trophoblast differentiation into syn-
cytiotrophoblast is associated with reduced acetylation of
multiple histone lysine residues.
Dynamic changes in genomic AcH3 binding during
syncytiotrophoblast development
Since syncytiotrophoblast development was associated
with reduced histone acetylation, our next goal was to use
chromatin immunoprecipitation sequencing to evaluate
Fig. 3 Reduced histone acetylation during syncytialization of BeWo trophoblasts. a Representative immunofluorescent images depicting
E-cadherin and CGB expression in BeWo trophoblasts cultured in undifferentiated and differentiation conditions. Nuclei were counterstained using
DAPI (blue). Please note the loss of E-cadherin in syncytialized cells, and increased production of CGB. b Transcript levels of various genes associated
with cytotrophoblast progenitor traits (TP63, TEAD4) and syncytiotrophoblast development (ERVW1, ERVFRD-1, ERVV1, ERVV2, OVOL1, HSD11B2, and
CGB) in cells cultured in undifferentiated and differentiation conditions. c Levels of AcH2BK5, AcH3K9, AcH3K27, AcH3K14, AcH3K18, AcH3, CGB, and
total H3 were determined by western blotting. Densitometric analysis relative to total histone H3 is shown below the representative western blots.
The dotted line represents signal intensity in undifferentiated cells. Graphs represent means ± SEM. Data significantly different from undifferentiated
cells are indicated by an asterisk (*P < 0.05; n= 3). Scale bars represent 80 μm.
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Fig. 4 Dynamic changes in genomic AcH3 binding during trophoblast differentiation. a Pie chart showing total number of AcH3 peaks, and
the number of peaks that increased or decreased AcH3 binding during syncytiotrophoblast development by at least twofold (Padj < 0.01). b Top 10
chromosomal regions exhibiting decreased (black bars) and increased (blue bars) AcH3 binding during differentiation. Genes located proximate
(<1 kb) to these chromosomal areas are included above each bar. c Representative genome browser views of chromosomal regions proximate to
LHX4, (ΔN)TP63, TEAD4, CGB, OVOL1, and SYDE1, which exhibit differential AcH3 binding in undifferentiated and differentiation conditions.
d Immunohistochemistry for TEAD4 and CGB on first trimester human placental sections. Arrowheads denote syncytiotrophoblast; arrows point to
cytotrophoblasts. Scale bars represent 50 μm.
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site-specific changes in histone H3 acetylation in undif-
ferentiated BeWo trophoblasts versus cells undergoing
differentiation. We identified 50,678 AcH3 peaks genome
wide, of which 433 peaks were significantly changed at
least twofold (Padj < 0.01) between undifferentiated and
differentiated cells. One hundred and thirty-four peaks
(30.9%) exhibited at least twofold higher H3 acetylation in
undifferentiated cells, whereas higher H3 acetylation in
differentiation conditions was detected at 299 peaks
(69.1%, Fig. 4a). The top ten chromosomal regions exhi-
biting higher AcH3 occupancy in undifferentiated cells
and differentiated cells are shown in Fig. 4b. Interestingly,
ten of the top twenty peaks that exhibited robust deace-
tylation during differentiation aligned to chromosomes 1
and 5, whereas eight of the top twenty peaks showing
increased acetylation were located on chromosomes 14
and 19, which is consistent with a large number of genes
on these chromosomes expressed in syncytiotropho-
blast27. Increased AcH3 binding in undifferentiated cells
was also identified near genes previously associated with
cytotrophoblast stem traits (TEAD4 at chr12:3066251-
3068900, TP63 at chr3:189507601-189509350, Fig. 4c,
both P < 0.01; TEAD4 localized to cytotrophoblasts in
human placenta is shown in Fig. 4d). Increased AcH3 in
differentiated cells was consistently detected close to
genes associated with syncytiotrophoblast development
and function (CGB at chr19:49525501-49525850, OVOL1
at chr11:65554451-65557400, ERVW1 at chr7:92098079-
92099695, ERVFRD-1 at chr6:11102722-11112071,
HSD11B2 at chr16:67465036-67471454, Fig. 4c and
Fig. S1, all P < 0.01; CGB localized to syncytiotrophoblast
in human placenta is shown in Fig. 4d). Additionally, we
also discovered several regions that exhibit differential
AcH3 levels located near genes that have not been pre-
viously associated with human syncytiotrophoblast
development. These novel targets include a
differentiation-associated increase in AcH3 near the gene
encoding synapse defective 1 (SYDE1), which is a Rho-
GTPase activating protein stimulated by glial cells miss-
ing-1, and is important for murine placentation and
Fig. 5 Effect of HDAC inhibition on histone acetylation and syncytiotrophoblast development. BeWo trophoblasts were exposed to the broad
spectrum HDAC inhibitor trichostatin A (TSA, 0–20 nM), and then induced to differentiate for 48 h. a Levels of AcH2BK5, AcH3K27, AcH3K14, histone
H3, CGB, and β-Actin (loading control) were determined by western blotting. b Transcript levels of ERVW1, ERVFRD-1, OVOL1, CGB, HSD11B2, and TP63
in cells cultured in undifferentiated (black bar) and differentiation (blue bars) conditions with or without various doses of TSA. c Percentage of fused
cells following culture in undifferentiated or differentiation conditions with or without 20 nM TSA. Representative images of E-cadherin (red) and CGB
(green) are shown to the left of the graph. Nuclei were counterstained using DAPI (blue). Scale bar represents 80 μm. Graphs represent means ± SEM.
Data significantly different from the Ctrl (0 nM TSA) cells cultured in differentiation conditions are indicated by an asterisk (*P < 0.05; n= 3 in (b), n= 9
images from three experiments in (c)).
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human trophoblast migration28. Decreased AcH3 binding
was detected during differentiation near LIM homeobox 4
(LHX4), which is important for development of the pla-
cental labyrinth zone in mice29.
HDAC inhibition prevents cytotrophoblast differentiation
Altered acetylation levels of multiple histone residues
during cytotrophoblast differentiation suggest that
HDACs may be important mediators of syncytiotropho-
blast development. To determine the impact of HDAC
activity on trophoblast differentiation, BeWo trophoblasts
were treated with the broad spectrum HDAC inhibitor,
TSA, and then induced to differentiate for up to 48 h.
TSA dose-dependently increased levels of AcH2BK5,
AcH3K27, and AcH3K14 (Fig. 5a). To determine the
impact of TSA on transcripts associated with cyto-
trophoblast differentiation, we assessed expression of
genes that change during differentiation (Fig. 5b). Expo-
sure of cells to TSA prior to commencing differentiation
dose-dependently inhibited expression of all genes that
are normally induced during differentiation, including
ERVW1, ERVFRD-1, OVOL1, CGB, and HSD11B2
(Fig. 5b, P < 0.05). In the presence of 10 and 20 nM TSA,
expression of TP63 was maintained at levels comparable
to undifferentiated cells (Fig. 5b). Furthermore, compared
with cells exposed to differentiation conditions for 48 h, in
which nuclei were frequently contained within fused cell
clusters (E-cadherin-negative, CGB-positive), 74.9% less
nuclei were detected within fused clusters in the presence
of 20 nM TSA (P < 0.05, Fig. 5c). Thus, inhibition of
HDAC activity prevented syncytiotrophoblast formation.
To test the efficacy of another broad-spectrum inhibitor
of HDAC activity on syncytiotrophoblast development,
BeWo trophoblasts were treated with various doses of
SAHA. Cells exposed to SAHA under differentiation
conditions exhibited a similar prevention of histone dea-
cetylation and dose-dependent restoration of transcript
expression comparable to levels detected in undiffer-
entiated cells, as was observed with TSA (Fig. S2).
Likewise, exposure of cells to SAHA prevented
Fig. 6 Effect of selective HDAC inhibitors on syncytiotrophoblast development. a RT-PCR depicting expression of HDAC1-10 in primary term
cytotrophoblasts (CTB) and BeWo trophoblasts. RNA18SN1 was used to ensure that a similar quantity of cDNA was used in PCR reactions.
b Percentage of BeWo trophoblasts that underwent syncytialization following culture in undifferentiated conditions (black bar), or differentiation
conditions (blue bars) in the presence of FK228, MS275, LMK235, BRD4345, CAY10683, or RGFP966. Please note that only the HDAC1/HDAC2 inhibitor
FK228 significantly inhibited cytotrophoblast differentiation. Representative images of E-cadherin (red) and CGB (green) in undifferentiated and
differentiation conditions with or without 5 nM FK228 is shown to the right of the graph. Nuclei were counterstained using DAPI (blue). Scale bar
represents 80 μm. c Transcript levels of ERVW1, ERVFRD-1, OVOL1, CGB, HSD11B2, and TP63 in cells cultured in undifferentiated and differentiation
conditions with or without various doses of FK228. Graphs represent means ± SEM. Data significantly different from control cells cultured in
differentiation conditions are indicated by an asterisk (*P < 0.05; n= 9 images from three experiments in (b), n= at least 4 in (c)).
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syncytiotrophoblast development by 72.7% (Fig. S2C, P <
0.05). Since both TSA and SAHA abrogated cytotropho-
blast differentiation, we conclude that HDAC activity is
required for syncytiotrophoblast development.
HDAC1 and HDAC2 are critical regulators of
cytotrophoblast differentiation
We next investigated the role of specific HDACs in
cytotrophoblast differentiation. First, we profiled expres-
sion of HDAC1 to HDAC10 in human primary cyto-
trophoblasts and BeWo trophoblasts (Fig. 6a). HDAC1,
HDAC2, HDAC3, HDAC4, HDAC5, and HDAC10 were
detectable in both primary cytotrophoblasts and BeWo
trophoblasts. HDAC6 and HDAC8 were detectable in
BeWo trophoblasts, but expression was low or undetect-
able in primary cytotrophoblasts. HDAC7 and HDAC9
were not detectable in either cell-type. To narrow our
search for specific HDACs involved in syncytiotropho-
blast development, cells cultured under differentiation
conditions were treated with small molecule inhibitors
that decrease activity of defined subsets of HDACs. Dose
and specificity of the HDAC inhibitors used in this study
are provided in Table 1. The only HDAC inhibitor that
prevented differentiation was the HDAC1/HDAC2 inhi-
bitor FK228 (71% decrease in fusion, P < 0.05, Fig. 6b).
The highest concentration of FK228 (5 nM) inhibited
expression of the differentiation-associated transcripts
ERVW1 (66.9%), ERVFRD-1 (82.6%), OVOL1 (68.6%),
CGB (51.9%), and HSD11B2 (73.9%, all P < 0.05), and
prevented differentiation-associated repression of TP63
by 75% (Fig. 6c, P < 0.05).
To further determine the biological significance of
HDAC1 in syncytiotrophoblast development, we deliv-
ered two-distinct shRNAs into BeWo trophoblasts, and
generated stable populations of cells with constitutively
decreased HDAC1 expression (HDAC1-KD1 and
HDAC1-KD2). Using this strategy, HDAC1 mRNA was
decreased by 87.5% in HDAC1-KD1 cells, and 64.6% in
HDAC1-KD2 cells compared with controls (P < 0.05,
Fig. S3A). HDAC1 protein was also substantially
reduced in both KD1 and KD2 cells (Fig. S3B). There
was no significant effect of HDAC1 knockdown on
mRNA expression of HDAC2, but an increase in
HDAC2 protein was apparent, which is consistent with
findings reported in other cells in which HDAC1 is
reduced or absent30. There was no significant effect of
HDAC1 deficiency on the ability of cells to differentiate
(Fig. S3D), nor was there any difference in transcript
expression of ERVFRD-1, HSD11B2, and TP63 (Fig. S3C).
A modest reduction of CGB expression was observed in
HDAC1-KD2 cells (54.4%, P < 0.05, Fig. S3C), but not in
HDAC1-KD1 cells.
We employed a similar strategy to decrease HDAC2
expression. Stable populations of BeWo trophoblasts
expressing shRNAs targeting HDAC2 exhibited reduced
mRNA levels of HDAC2 (90.5% and 87.6% decreased in
HDAC2-KD1 and HDAC2-KD2 cells, respectively, P <
0.05, Fig. S4A), and showed reduced HDAC2 protein
(Fig. S4B). Cells lacking HDAC2 were able to robustly
differentiate (Fig. S4D), and there were no consistent
differences in the expression of differentiation-associated
genes in HDAC2-KD1 and HDAC2-KD2 cells compared
with control cells (Fig. 4C). Thus, deficiency of HDAC1 or
HDAC2 is not sufficient to prevent syncytiotrophoblast
development.
Since HDAC1 and HDAC2 are highly similar proteins
that have the potential to compensate for each other31,
we next analyzed the impact of reduced expression of
both HDAC1 and HDAC2 on trophoblast differentiation
capacity. Stable populations of HDAC1-KD1 cells were
transduced with lentivirus carrying HDAC2-KD1
shRNAs, resulting in cells that exhibited a 59.6%
decrease in HDAC1 expression and 34.7% decrease in
HDAC2 expression (P < 0.05, Fig. 7a). Since expression of
both HDAC1 and HDAC2 was reduced, these cells are
henceforth referred to as “double knockdown” (DKD)
cells. DKD cells exhibited a mild proliferation defect
under undifferentiated conditions (not shown), which
may explain the reduced knockdown efficiency of
HDAC1 and HDAC2 in DKD cells, since some HDAC1/
HDAC2 expression is likely required in the undiffer-
entiated state. Under differentiation conditions, DKD
cells exhibited impaired differentiation capacity, includ-
ing reduced protein expression of CGB and increased
E-cadherin levels (Fig. 7b), and a 64.2% decrease in the
number of cells that underwent fusion (P < 0.05, Fig. 7d).
Furthermore, compared with control cells subjected to
differentiation conditions, DKD cells exhibited sig-
nificantly reduced expression of ERVW1 (45%),
ERVFRD-1 (45.8%), OVOL1 (60%), CGB (51%) and
Table 1 HDAC inhibitors used in this study.
Name Specificity Dose Company, catalog
BRD434566 HDAC5, HDCA9 1300 nM Sigma-Aldrich SML1706
CAY1068367 HDAC2 300 nM Cayman Chemical Co
15403-5
FK22868 HDAC1, HDAC2 5 nM Sigma-Aldrich SML1175
LMK23569 HDAC4, HDAC5 880 nM Sigma-Aldrich SML1053
MS27570 HDAC1, HDAC3 740 nM Cayman Chemical Co
13284-1
RGFP96671 HDAC3 160 nM Cayman Chemical Co
16917-1
SAHA72 Pan 50-750 nM Sigma-Aldrich SML0061
TSA73 Pan 1–20 nM Sigma-Aldrich T8552
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HSD11B2 (58%), and retained 2.3-fold higher expression
of TP63 (all P < 0.05, Fig. 7c). Chromatin immunopre-
cipitation analysis showed that, when cells were exposed
to differentiation conditions, DKD cells had reduced
AcH3 enrichment proximate to the transcription start
site of both HSD11B2 and OVOL1 compared with con-
trol cells (Fig. S5). Collectively, these findings indicate
that DKD cells have a reduced capacity to differentiate,
indicating that HDAC1 and HDAC2 are critical media-
tors of syncytiotrophoblast development.
Discussion
In the present study, we found that global acetylation
of core histones is altered during progression of cyto-
trophoblast differentiation into syncytiotrophoblast.
We also identified dynamic changes in histone acet-
ylation during trophoblast differentiation, including
site-specific changes at loci that require transcriptional
regulation during differentiation, and showed that
HDAC activity is critical for syncytiotrophoblast for-
mation. Collectively, our discoveries provide novel
Fig. 7 Knockdown of HDAC1 and HDAC2 inhibits syncytiotrophoblast development. a Expression of HDAC1 and HDAC2 in BeWo trophoblasts
expressing control (scrambled, SCR) shRNA or shRNAs targeting HDAC1 and HDAC2 (double knockdown, DKD) cultured in undifferentiated (black
bars) and differentiation (blue bars) conditions. b Western blot showing protein levels of HDAC1, HDAC2, E-cadherin, and CGB in SCR and DKD cells
cultured in undifferentiated and differentiation conditions. β-Actin shown in the third blot (from top) served as a loading control for HDAC1 and
HDAC2 blots; β-Actin shown in the sixth blot served as a loading control for E-cadherin and CGB. c Transcript levels of ERVW1, ERVFRD-1, OVOL1, CGB,
HSD11B2, and TP63 in SCR and DKD cells cultured in undifferentiated and differentiation conditions. d Percentage of SCR and DKD cells that
underwent syncytialization (E-cadherin-negative, CGB-positive) following culture in undifferentiated or differentiation conditions. Representative
images of E-cadherin (red) and CGB (green) is shown above the graph. Nuclei were counterstained using DAPI (blue). Graphs represent means ± SEM.
Data significantly different from SCR cells cultured in differentiation conditions are indicated by an asterisk (*P < 0.05; n= at least 4 in (a) and (c), n=
18 images from six experiments in (d). In (c) and (d), statistical comparisons are shown only for differentiation conditions). Scale bars represent 80 μm.
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insights into the epigenetic mechanisms of syncytio-
trophoblast development.
Reversible acetylation of specific lysine residues in his-
tone proteins is a major component of the epigenetic code
that regulates chromatin accessibility. The acetylation
status of histones is controlled through the competing
actions of HDACs and histone acetyltransferases, which
have a pivotal role in controlling gene expression during
cell homeostasis, proliferation, and differentiation. In the
current study, we found that coordination of cyto-
trophoblast differentiation into syncytiotrophoblast was
associated with reduced acetylation of multiple histone
lysine residues. Syncytialization is associated with a mul-
titude of transcriptional changes32, so it was surprising to
observe a robust decrease in histone acetylation during
the progression of differentiation. One potential expla-
nation is that histone hypoacetylation is required to
transiently exit the epithelial state in order to facilitate
syncytialization. High levels of histone acetylation are
associated with maintenance of the epithelial phenotype33,
and histone deacetylation is implicated with repression of
epithelial characteristics and transition to a mesenchymal
state34,35. While there is no evidence that syncytio-
trophoblast formation requires a mesenchymal transfor-
mation, syncytialization necessitates repression of
epithelial junctional proteins such as E-cadherin. In line
with our study, differentiation of mouse trophoblast stem
cells into (predominantly) trophoblast giant cells is asso-
ciated with decreased acetylation of H2AK5, H2BK5,
H2BK12, H2BK15, H2BK20, H3K9, and H4K8, as well as
loss of E-cadherin36. Thus, histone deacetylation may be a
conserved feature of trophoblast differentiation.
Since HDACs catalyze histone deacetylation, we next
sought to determine the importance of HDAC activity for
syncytialization. We found that the pan-HDAC inhibitors
TSA and SAHA, and the selective HDAC1/HDAC2
inhibitor FK228, all robustly inhibited cytotrophoblast
differentiation, implicating HDAC1/HDAC2 activity as a
critical determinant of syncytiotrophoblast development.
HDAC1 and HDAC2 exhibit 86% amino acid sequence
identity, and are recruited to appropriate sites by binding
to transcription factors as homodimers or heterodimers,
or being part of multi-component complexes37–39. Their
ubiquitous expression, incorporation into similar
recruitment complexes, deacetylase activity toward com-
mon substrates, and high homology all suggest that
HDAC1 and HDAC2 are largely redundant and can
compensate for a functional loss of the other. Indeed,
mice exhibiting tissue-specific inactivation of Hdac1 or
Hdac2 in epidermis17, B cells40, T cells41, cardiomyo-
cytes31, endothelial cells42, neuronal precursors43, neural
crest44, smooth muscle45, and oligodendrocytes46, all do
not exhibit an obvious phenotypic defect, whereas loss of
both Hdac1 and Hdac2 results in severe phenotypes in
these tissues47. However, in mice, global deletion of
Hdac1 results in embryonic lethality at midgestation48,
which is an effect not observed in mice lacking Hdac2,
indicating that HDAC1 and HDAC2 exhibit at least some
distinct biological functions. In the current study, we
found that cytotrophoblasts expressed HDAC1 and
HDAC2, and that knockdown of either HDAC1 or
HDAC2 did not impact syncytiotrophoblast formation.
Interestingly, in cells with reduced HDAC1 or HDAC2, we
observed increased expression of the paralogous protein,
which is consistent with results in other studies40,49,50.
However, inhibition of both HDAC1 and HDAC2 using
FK228, or knockdown of both HDAC1 and HDAC2,
inhibited cytotrophoblast differentiation, suggesting that
HDAC1 and HDAC2 can compensate for each other
during syncytiotrophoblast development.
In this study, we used three human cytotrophoblast
models to assess acetylation patterns during the pro-
gression of syncytialization: primary cytotrophoblast cells
isolated from term placentas, human trophoblast stem
cells derived originally from first trimester placentas25,
and BeWo trophoblasts. All three models of differentiat-
ing trophoblasts showed reduced histone acetylation at
multiple lysine residues during the progression of syncy-
tialization. Of note, experiments investigating the role of
HDAC inhibition on syncytiotrophoblast development
were performed primarily using BeWo trophoblasts, since
isolated cytotrophoblasts harbor very few cycling cells and
spontaneously initiate differentiation shortly following
isolation, and culture conditions to maintain human tro-
phoblast stem cells in an undifferentiated state require the
use of the HDAC inhibitor, valproic acid. Although BeWo
trophoblasts are a transformed line with certain limita-
tions, they do possess the capacity to rapidly transition
from a proliferative state to a differentiated state on sti-
mulus, and exhibit gene expression changes, fusion, and
hormone production reminiscent of the switch between
cytotrophoblasts and fused syncytiotrophoblast in vivo.
These cells are thus an advantageous tool for investigating
molecular mechanisms associated with the conversion
between cytotrophoblast proliferation and differentiation.
Collectively, our findings indicate that histone deacetyla-
tion is likely a transient necessity for syncytialization, and
is consistent with our in situ evidence that histone acet-
ylation is apparent in a subset of syncytiotrophoblast
nuclei.
In conclusion, we identified dynamic global and site-
specific changes in AcH3 levels at key chromosomal
regions during cytotrophoblast differentiation, which
reveals new insights into regulatory mechanisms of gene
expression changes during syncytiotrophoblast formation.
It will be interesting to investigate these chromosomal
regions, and genes located near these sites, for putative
roles in syncytiotrophoblast development and function.
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It will also be interesting to uncover the role of histone
deacetylation and HDAC1/HDAC2 activity in the reg-
ulation of extravillous trophoblast lineage development,
and investigate the possibility of proteins other than his-
tones whose activity is impacted by (de)acetylation. Our
results caution against the use of HDAC inhibitors as
front-line therapies in pregnant women diagnosed with
cancer due to possible effects on placental function, and
highlight the possibility of using clinically approved
HDAC inhibitors in specific obstetric pathologies char-
acterized by aberrant cytotrophoblast differentiation.
Materials and methods
Collection of human placentae
Placental tissues were obtained with written informed
consent from patients undergoing elective termination of
pregnancy (first trimester placenta samples) or elective
cesarean section (term placenta samples) at London
Health Sciences Centre (London, ON, Canada) following
approval by the Research Ethics Boards at the University
of Western Ontario and London Health Sciences Centre.
Paraffin-embedded sections and flash-frozen samples of
gestational age 6-week and 39-week human placenta were
obtained from the Research Centre for Women’s and
Infant’s Health Biobank (RCWIH, Mount Sinai Hospital,
Toronto, ON, Canada, http://biobank.lunenfeld.ca), fol-
lowing appropriate consent, under protocols approved by
Mount Sinai Hospital and the University of Western
Ontario research ethics boards.
Isolation of primary cytotrophoblast cells
Isolation of primary cytotrophoblast cells from term
placenta was conducted according to the protocol by
Kliman et al.51, with modifications. Briefly, villous tissue
was thoroughly washed with phosphate buffered saline
(PBS), scraped using a glass slide, and minced. Minced
villous tissue was then digested in digestion buffer (Hank’s
Balanced Salt Solution supplemented with 1M HEPES,
7.5% sodium bicarbonate, 2.5% trypsin, and 150 kU
deoxyribonuclease I, Sigma-Aldrich, Oakville, ON,
Canada) at 37 °C for 30 min on a magnetic stirrer. Sus-
pended cells were collected and immersed in fetal bovine
serum (FBS, ThermoFisher Scientific, Mississauga, ON,
Canada) to inhibit enzymatic activity. The remaining tis-
sue was subjected to two additional 30 min cycles of
enzymatic digestion. Cell suspensions were filtered
through a 100 μm strainer to remove contaminating tissue
debris, and then centrifuged at 1000 × g for 10 min. Cell
pellets were resuspended in DMEM-F12 medium sup-
plemented with 10% FBS, layered on top of a preformed
Percoll gradient (consisting of dilutions of Percoll from 70
to 5%) and centrifuged at 1200 × g for 20 min without
braking. The layer between 45 and 35% Percoll (con-
taining cytotrophoblast cells) was collected, suspended in
DMEM-F12 medium and centrifuged at 350 × g for
10 min. To remove residual non-cytotrophoblast cells, 107
cells were resuspended in 100 μl MACS separation buffer,
and incubated with 10 μl of phycoerythrin-conjugated
anti-human leukocyte antigen-ABC antibody (catalog
130-120-431, Miltenyi Biotec, Auburn, CA) for 10 min at
4 °C. After washing, cells were resuspended in 80 μl buffer
and incubated with 20 μl of anti-phycoerythrin-coated
microbeads for 15min at 4 °C. Cell pellets were washed
and resuspended in 500 μl buffer. Cells expressing human
leukocyte antigen-ABC (non-cytotrophoblast cells) were
positively selected using a magnetic separation column
and a MiniMACSTM separator (Miltenyi Biotec). The
remaining cells that passed through the column were
counted, and cell viability was determined by trypan blue
exclusion. We consistently achieved >90% viable cyto-
trophoblasts using this method. 2 × 105 cytotrophoblasts/
cm2 were cultured at 37 °C, 5% CO2 in DMEM-F12 media
supplemented with 10% FBS, 100 units/ml penicillin, and
100 μM streptomycin (Sigma-Aldrich) for up to 72 h,
during which time cells spontaneously formed
syncytiotrophoblast.
Culture of cell lines
Human trophoblast stem cells, derived from human
6-week placenta25, were maintained in DMEM-F12
media. Cells were passaged by using TrypLE (Thermo-
Fisher Scientific) prior to reaching confluency and were
maintained at 37 °C in an atmosphere consisting of 5%
CO2 for no more than twenty sequential passages. Human
trophoblast stem cells were maintained in a stem state, or
induced to differentiate into syncytiotrophoblast for up to
5 days, using culture conditions described previously25.
BeWo trophoblasts are a well-characterized trans-
formed human trophoblast cell line that exhibit cyto-
trophoblast characteristics52. BeWo cells were obtained
from American Type Culture Collection (CCL-98, Man-
assas, VA), and were routinely tested by short tandem
repeat profiling and for mycoplasma to authenticate cells
and ensure consistency across passages. Cells were
maintained at 37 °C, 5% CO2 in DMEM-F12 media sup-
plemented with 10% FBS, 100 units/ml penicillin, and
100 μM streptomycin (Sigma-Aldrich). Differentiation of
BeWo trophoblasts into syncytiotrophoblast was induced
by exposing cells to a brominated, cell permeable deri-
vative of cAMP, 8-Br-cAMP (Sigma-Aldrich, 250 μM) for
up to 48 h, as we have done previously53.
Human embryonic kidney (HEK)-293T cells were
obtained from American Type Culture Collection (CRL-
3216). HEK-293T cells were maintained in DMEM sup-
plemented with 10% FBS, 100 units/ml penicillin, and
100 μM streptomycin. Cells were passaged by light tryp-
sinization prior to reaching confluency and were main-
tained at 37 °C with 5% CO2.
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Immunohistochemistry
Serial sections of human placental tissue were depar-
affinized in Histoclear, and rehydrated using increasing
dilutions of ethanol washes. Formaldehyde crosslinks
were fragmented by placing slides in Reveal Decloaker
(Biocare Medical, Pacheco, CA) at 95 °C for 20min. Sec-
tions were then permeabilized using PBS containing 1%
bovine serum albumin and 0.3% Triton-X, and non-
specific antibody binding was reduced by immersing
slides in 10% normal goat serum (ThermoFisher Scien-
tific). Sections were immersed in primary antibodies
specific for AcH2BK5 (1:100, catalog 2574), AcH3K9
(1:800, catalog 9649), AcH3K27 (1:100, catalog 8173),
AcH3K14 (1:400, catalog 7627), AcH3K18 (1:100, catalog
13998), CGB (1:100, catalog PA5-58598, ThermoFisher
Scientific), and TEAD4 (1:50, catalog HPA056896, Sigma-
Aldrich) overnight at 4 °C. Unless indicated otherwise, all
antibodies were obtained from Cell Signaling Technology
(Danvers, MA). The next day, sections were incubated for
1 h with species-appropriate fluorescent-conjugated anti-
bodies (Alexa Fluor, ThermoFisher Scientific), and then
incubated with 4′6-diamidino-2-phenylindole (DAPI,
ThermoFisher Scientific) to detect nuclei. Slides were
mounted using Fluoromount G (SouthernBiotech, Bir-
mingham, AL) and imaged using a Nikon ECLIPSE Ni
series microscope equipped with a Ds-Qi2 camera.
Western blotting
Evaluation of protein expression was determined by
western blotting. Cell lysates were prepared using radio-
immunoprecipitation assay buffer (RIPA: 50mM Tris,
150mM NaCl, 1% NP-40, 0.5% sodium deoxycholate,
0.1% sodium dodecyl sulfate (SDS)). Approximately 50 μg
of cell lysate was mixed with 4× reducing loading buffer
(0.25M Tris, 8% SDS, 30% glycerol, 0.02% bromophenol
blue, 0.3M dithiothreitol), boiled for 5 min, and subjected
to SDS-polyacrylamide gel electrophoresis. Proteins were
transferred to polyvinylidene difluoride membranes,
blocked in tris buffered saline containing 3% bovine
serum albumin and 0.5% Tween-20, and probed overnight
at 4 °C using antibodies for AcH2BK5 (1:1000), AcH3K9
(1:1000), AcH3K27 (1:1000), AcH3K14 (1:1000),
AcH3K18 (1:1000), acetylated H3 (1:10000, catalog 06-
599, Sigma-Aldrich), total H3 (1:1000, catalog 499, Cell
Signaling Technology), HDAC1 (1:1000, catalog 5356,
Cell Signaling Technology), HDAC2 (1:1000, catalog
5113, Cell Signaling Technology), CGB (1:2000), E-
cadherin (1:1000, catalog 14472, Cell Signaling Technol-
ogy), and β-actin (1:4000, catalog sc47778, Santa Cruz
Biotechnology, Santa Cruz, CA). Except where indicated,
the antibodies used for western blotting are the same as
those used for immunohistochemistry. All primary anti-
bodies were diluted in tris buffered saline containing 0.5%
Tween-20 and 3% bovine serum albumin. Membranes
were then washed, incubated for 1 h with species-
appropriate infrared-conjugated secondary antibodies
(Cell Signaling Technology), and signals detected using a
LI-COR Odyssey imaging system (LI-COR Biosciences,
Lincoln, NE). Densitometric analysis of signal intensity
was conducted using ImageJ (version 1.52a)54.
Immunofluorescence
Cells were fixed with 4% paraformaldehyde and then
permeabilized using PBS containing 0.3% Triton-X and
1% bovine serum albumin. Nonspecific antibody binding
was blocked by immersing cells in 10% normal goat serum
(ThermoFisher Scientific), and then cells were probed
with mouse primary antibody specific for human E-
cadherin (1:50, catalog 14472, Cell Signaling Technology)
or rabbit primary antibody specific for cytokeratin 7
(1:100, catalog PA5-86169, ThermoFisher Scientific)
overnight at 4°C. The next day, cells were incubated with
Alexa Fluor 555 anti-mouse or anti-rabbit secondary
antibodies for cells incubated with E-cadherin and cyto-
keratin 7, respectively. Cells that were previously
immersed in the antibody targeting E-cadherin were then
incubated with rabbit anti-human CGB (1:1000), followed
by Alexa Fluor 488-conjugated anti-rabbit secondary
antibody. Nuclei were then counterstained using DAPI.
Images were captured using a Zeiss Axio fluorescence
microscope. For quantification of trophoblast fusion,
images were taken from three randomly selected fields per
well in triplicate at ×20 magnification. The percent fusion
was calculated by counting the total number of nuclei
contained within fused cells (E-cadherin negative, CGB-
positive) divided by the total number of nuclei. Cell
counting was conducted using an in-house cell counting
program designed in MATLAB.
RT-PCR
RNA was extracted using Ribozol (VWR International,
Mississauga, ON, Canada), according to the manu-
facturer’s instructions. RNA was converted into cDNA
using reverse transcription (High Capacity cDNA kit,
ThermoFisher Scientific), which was then diluted 1:10.
Conventional PCR was conducted using primers descri-
bed in Table 2, and DreamTaq DNA Polymerase (Ther-
moFisher Scientific) to amplify cDNA. Cycling conditions
involved an initial holding step (95 °C for 3 min), followed
by 33 cycles of PCR (95 °C for 30 s, 55–63 °C for 30 s, and
72 °C for 30 s), and a final elongation phase at 72 °C for
12min. PCR products were resolved on 2% agarose gels
and imaged using a ChemiDoc imaging system (Bio-Rad
Laboratories, Mississauga, ON, Canada). Quantitative
PCR was performed by amplifying cDNA using Sensifast
SYBR Green PCR Master Mix (FroggaBio, Toronto, ON,
Canada) and primers shown in Table 2. A CFX96 Connect
real-time PCR detection system (Bio-Rad Laboratories)
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was used to detect fluorescence. Cycling conditions
involved an initial holding step (95 °C for 10min). Fol-
lowing this step, 40 cycles of two step PCR (95 °C for 15 s
and 60 °C for 1 min) and a dissociation phase were per-
formed. Relative mRNA expression was calculated using
the ΔΔCt method55. The geometric mean from three
constitutively expressed reference genes (RNA18SN1,
EEF2, YWHAZ) was used as reference RNA.
Chromatin immunoprecipitation sequencing
Chromatin immunoprecipitation was performed as
previously described53. Briefly, cells cultured under con-
trol and differentiated conditions were fixed with 0.7%
formaldehyde for 10min, and purified nuclear lysates
were sonicated using a Bioruptor (Diagenode, Denville,
NJ) to prepare DNA fragments at a size of ~200–400 bp.
Approximately 1% of sonicated nuclear lysate was
removed to serve as an input control. Half of the
remaining lysate was incubated with AcH3 antibody (5 μg,
Sigma-Aldrich catalog 06-599) overnight at 4 °C. The
other half was incubated with rabbit IgG (5 μg, catalog
2729, Cell Signaling Technology) overnight at 4°C to serve
as a nonspecific binding control. The next day, immu-
noprecipitated chromatin fragments were captured using
protein G-conjugated Sepharose beads (Sigma-Aldrich).
Eluted and purified DNA fragments were amplified using
DreamTaq DNA polymerase (ThermoFisher Scientific)
and primers described in Table 2, or analyzed using an
Agilent Bioanalyzer (Agilent Technologies, Santa Clara,
CA), quantified using Qubit, and libraries generated using
a NEBNext Ultra II DNA Library Prep Kit (New England
Biolabs, Whitby, ON, Canada). Libraries were sequenced
on an Illumina (San Diego, CA) NextSeq High Output at
the London Regional Genomics Facility using 75-bp single
end reads, which generated at least 42 million reads per
sample.
Raw reads were trimmed with the TrimGalore wrapper
script around the sequence-grooming tool cutadapt
Table 2 List of primers used for RT-PCR and chromatin immunoprecipitation (ChIP).
Gene Forward Reverse Accession No.
CGB CCTGGCCTTGTCTACCTCTT GGCTTTATACCTCGGGGTTG NM_000737.3
ChIP-HSD11B2 GGGACTGGACACTCAACAGG AGAACTCTCCCACTCTTGCG NC_000016.10
ChIP-OVOL1 CCACCCTCACCTGTGTTTGA GGCTCAGCTCACCTTTACCA NC_000011.10
EEF2 AGGCGTAGAACCGACCTTTG GACAGCGAGGACAAGGACAA NM_001961.4
ERVV1 TAACAGTGGGGCGATAGAGG AGACTTCACAGCCTCCCAAA NM_152473.2
ERVV2 CAGGCACAGTGGAATGAAAA GACCTGGTGATGAAGTTGTGG NM_001191055.2
ERVFRD-1 CCAAATTCCCTCCTCTCCTC CGGGTGTTAGTTTGCTTGGT NM_207582.3
ERVW1 CTACCCCAACTGCGGTTAAA GGTTCCTTTGGCAGTATCCA NM_001130925.2
HDAC1 TCGATCTGCTCCTCTGACAA GCTTCTGGCTTCTCCTCCTT NM_004964.3
HDAC10 ATGGCCAGGGGATCCAGTAT TTTGCCCCTCAAAGGCCAGT NM_001159286.2
HDAC2 TGTGCCTCAGTTGCTTCATC GATGCAGTGAGCCAAGATCA NM_001527.4
HDAC3 GGAGCTGGACACCCTATGAA GACTCTTGGTGAAGCCTTGC NM_001355039.2
HDAC4 CAAGCACCCCTCGTCACAG GCCTCTTCCTCATCGCTCTC NM_006037.3
HDAC5 AGCAAAAGCCCAACATCAAC AACTTCTGCACACAGCTCCA NM_001015053.2
HDAC6 AGGTCGCCAGAAACTTGGTG TGGGGGTTCTGCCTACTTCT NM_001321225.2
HDAC7 CTCTCGCCGTCTCACAGTC TCGCTTGCTCTTGTCCTTGT NM_001098416.4
HDAC8 AAGCAGATGAGAGATGAAGCA TGCCAATTCCCACTGGAGTC NM_001166418.2
HDAC9 CCTTTTTGCTTCTGCCTCACC CAGCCACAGAATAGCACCCA NM_001204144.3
HSD11B2 CAGATGGACCTGACCAAACC AGCTCCGCATCAGCAACTAC NM_000196.4
OVOL1 CCGTGCGTCTCCACGTGCAA GGCTGTGGTGGGCAGAAGCC NM_004561.4
RNA18SN1 GCAATTATTCCCCATGAACG GGCCTCACTAAACCATCCAA NR_145820.1
TEAD4 CAGTATGAGAGCCCCGAGAA TGCTTGAGCTTGTGGATGAA NM_003213.4
TP63 CAGATGGACCTGACCAAACC AGCTCCGCATCAGCAACTAC NM_001114978.2
YWHAZ ATGCAACCAACACATCCTATC GCATTATTAGCGTGCTGTCTT NM_001135699.1
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version 0.4.1 with the following quality trimming and
filtering parameters56. The trimmed reads were mapped
onto the hg19 reference genome downloaded from
UCSC genome browser57, using HISAT2 version 2.0.4
(‘–no-spliced-alignment’)58. SAMtools (http://samtools.
sourceforge.net/) was then used to convert SAM files
and index BAM files. BigWig coverage tracks were gen-
erated using deepTools2 from the aligned reads59. The
coverage was calculated as the number of reads per 50 bp
bin and normalized by 1× sequencing depth (effective
hg19 genome size= 2,509,729,011).
A sliding window approach implemented in the csaw R/
Bioconductor package was used to identify regions enri-
ched in AcH360. In brief, reads outside of blacklist regions
(https://github.com/Boyle-Lab/Blacklist) with mapq ≥ 20
were counted inside 200-bp sliding windows. Global
background was estimated by counting reads within
contiguous 2000-bp bins across the genome. Windows
were filtered out if the fold enrichment was below log2(3)
compared with background. Filtered windows less than
100 bp apart were merged and a maximum region size of
5000 bp was permitted, conferring a total of 49,648
regions. We performed differential binding analysis of
count data within these regions using DESeq2 R/Bio-
conductor package61, and used the independent hypoth-
esis weighting R/Bioconductor package to weight P-values
and adjust for multiple testing62,63. Raw and processed
data is deposited in NCBI’s Gene Expression Omnibus
(GSE141867)64.
Treatment of trophoblasts with HDAC small molecule
inhibitors
BeWo trophoblasts were pretreated with pan and spe-
cific HDAC inhibitors. After 2 h of HDAC inhibitor
treatment, the cells were induced to differentiate by
treating with 250 μM 8-Br-cAMP. The doses and speci-
ficity of the inhibitors used in this study are detailed in
Table 1. All inhibitors were dissolved initially in dimethyl
sulfoxide (DMSO) except TSA, which was dissolved
initially in ethanol. Thus, additional controls were inclu-
ded in which cells were exposed to either 0.1% DMSO or
0.005% ethanol (the highest concentrations of vehicle in
which cells were exposed during experiments). For all
inhibitors, there was no obvious effect on cell viability at
the doses used, nor did the vehicle in which the inhibitors
were dissolved affect cytotrophoblast viability or
differentiation.
Lentivirus production and shRNA-mediated gene
knockdown
Two-distinct HDAC1 and HDAC2 knockdown shRNA
constructs encoded in PLKO.1 vectors were obtained




Control shRNA (scrambled) constructs that do not target
any known mammalian genes were obtained from
Addgene (plasmid 1864, Cambridge, MA). To establish
HDAC1/HDAC2 DKD, the puromycin resistance cas-
settes encoded within the shHDAC1-KD1 and Control
PLKO.1 vectors were replaced with a cassette encoding
blasticidin resistance. Lentiviral plasmids (MD2.G,
MDLG/RRE, and RSV-Rev) were used to produce lenti-
virus, as previously described65. HEK293T cells were
transfected using Lipofectamine 2000 (ThermoFisher
Scientific) in Opti-MEM medium (ThermoFisher Scien-
tific) with the shRNA containing vectors and packaging
plasmids. Culture supernatants containing lentivirus were
collected every 24 h for a total of 48 h, centrifuged, and
stored at −80 °C until use.
Human BeWo trophoblasts were exposed to lentiviral
particles for 48 h in the presence of hexadimethrine bro-
mide (8 μg/ml, Sigma-Aldrich) diluted in normal growth
medium. After 48 h, transduced cells were selected using
puromycin (3.5 μg/ml, ThermoFisher Scientific) or blas-
ticidin (2.5 μg/ml, ThermoFisher Scientific) for at least
48 h. A negative control well containing cells that were
not exposed to virus was used to ensure efficient
transduction.
Enzyme immunoassay
The concentration of CGB in supernatants of primary
cytotrophoblasts was measured by an enzyme immu-
noassay (catalog DY9034-05, R&D Systems, Minneapolis,
MN), using a protocol provided by the manufacturer.
Briefly, conditioned media were collected from tropho-
blast cultures, centrifuged to remove debris, and super-
natants added to a microplate precoated with a
monoclonal antibody specific to CGB. After washing, a
biotinylated rabbit anti-human CGB antibody was added,
followed by streptavidin conjugated to horseradish per-
oxidase. Excess solution was washed, and the peroxidase
substrate 3,3′,5,5′-tetramethylbenzidine was added to the
microplate to generate a colorimetric reaction. The
reaction was stopped by adding 2 N H2SO4, and absor-
bance was measured in a spectrophotometer at 450 nm.
To calculate the concentration of CGB in trophoblast
supernatants, absorbance was compared with a standard
curve, generated by graphing absorbance values relative to
known CGB concentrations.
Statistical analysis
For isolation of primary cytotrophoblasts, four different
placentas were used. All placentas were deemed to be
from uncomplicated pregnancies, and there were no
major differences in the number or quality of cyto-
trophoblasts from each placenta. For chromatin
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immunoprecipitation-sequencing experiments, immuno-
precipitated DNA from three independent replicates of
undifferentiated cells and three independent replicates of
differentiated cells were used. Inputs from undiffer-
entiated and differentiated cells from each experiment
were combined prior to sequencing. All other experi-
ments were repeated at least three independent times.
Variance was similar between groups being statistically
compared. Statistical comparisons for densitometry ana-
lyses were tested using one sample t-test, all other com-
parisons were tested using analysis of variance, followed
by Tukey’s post-hoc test. Means were considered statis-
tically different if P < 0.05. GraphPad Prism 6.0 and
MATLAB were used for all graphing and statistical ana-
lyses. All graphs represent means ± SEM.
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